title: Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats.
abstract: Although glutamine status in the critically ill patient can be improved by nutritional means, the most effective way of effecting such supplementation has received little attention. We evaluated two different ways of supplementing clinical nutrition products with glutamine, either with free glutamine or by providing a glutamine-rich protein source, in acute glucocorticoid-treated (intraperitoneal dexamethasone, 120 mg/kg) rats. During the recovery period, the animals received isonitrogenous and isoenergetic diets containing either casein, mixed whey proteins with or without glutamine, or carob protein plus essential amino acids. Plasma and tissue amino acids and glutathione as well as tissue protein synthesis were measured. Dexamethasone treatment lowered weight gain, muscle glutamine, and muscle and jejunal protein synthetic rate. Muscle protein synthesis was increased (from 15.9% to 24.2%/d) only when glutamine was included in the diet as a free amino acid. This increase paralleled a rise in plasma glutamine. We speculate that glutamine provided in dietary protein is extensively metabolized by the splanchnic tissues and does not influence peripheral glutamine status to the same extent as glutamine provided in a free amino acid form. However, both forms of glutamine supplementation were equally effective in increasing protein synthesis in the jejunum (by 25%). This is likely the main benefit of glutamine supplementation of enteral nutrition formulas.
authors.affiliation: Nestlé Research Center, Vers-chez-les-Blanc, 1000 Lausanne 26, Switzerland. julio.boza@rdls.nestle.com
authors.forename: J J
authors.initials: JJ
authors.lastname: Boza
authors.forename: M
authors.initials: M
authors.lastname: Turini
authors.forename: D
authors.initials: D
authors.lastname: Moënnoz
authors.forename: F
authors.initials: F
authors.lastname: Montigon
authors.forename: J
authors.initials: J
authors.lastname: Vuichoud
authors.forename: N
authors.initials: N
authors.lastname: Gueissaz
authors.forename: G
authors.initials: G
authors.lastname: Gremaud
authors.forename: E
authors.initials: E
authors.lastname: Pouteau
authors.forename: C
authors.initials: C
authors.lastname: Piguet-Welsch
authors.forename: P A
authors.initials: PA
authors.lastname: Finot
authors.forename: O
authors.initials: O
authors.lastname: Ballèvre
mesh_terms: D000596:Amino Acids / Q000097:blood; D000818:Animals; D003907:Dexamethasone / Q000008:administration & dosage; D019587:Dietary Supplements; D005938:Glucocorticoids / Q000008:administration & dosage; D005973:Glutamine / Q000008:administration & dosage* / Q000032:analysis / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009124:Muscle Proteins / Q000096:biosynthesis / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism; D014176:Protein Biosynthesis; D011506:Proteins / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D015430:Weight Gain
chemical_list: D000596:Amino Acids; D005938:Glucocorticoids; D009124:Muscle Proteins; D011506:Proteins; D005973:Glutamine; D003907:Dexamethasone